SARS-CoV-2 Spike-Heat Shock Protein A5 (GRP78) Recognition may be Related to the Immersed Human Coronaviruses

被引：34
|
作者：
Elfiky, Abdo A. [1 ]
机构：
[1] Cairo Univ, Biophys Dept, Fac Sci, Giza, Egypt
来源：
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词：
GRP78; HSPA5; SARS-CoV-2; viral attachment; spike; host-cell recognition; COVID-19; cross-vaccination;
D O I：
10.3389/fphar.2020.577467
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The human coronavirus (HCoV), SARS-CoV-2, caused more than 34 M confirmed infections from which more than 1 M deaths are reported until now (the WHO situation report-154). The current pandemic causes severe socio-economic burden. Due to the importance of understanding of the mode of recognition and viral entry, spike protein shed drug designers as the first look protein target with the first released solved structure on 26 February 2020 (PDB ID: 6VSB). It is proposed that the recognition site for GRP78 is found in SARS-CoV-2 and the immersed human coronaviruses but experimental validation is still required.
引用
收藏
页数：3
相关论文
共 35 条
  • [1] SARS-CoV-2 Spike Protein-Derived Cyclic Peptides as Modulators of Spike Interaction with GRP78
    Johnson, Nicholas
    Pattinson, Craig
    Burgoyne, Kate
    Hijazi, Karolin
    Houssen, Wael E.
    Milne, Bruce F.
    CHEMBIOCHEM, 2024, 25 (12)
  • [2] Zika virus envelope - heat shock protein A5 (GRP78) binding site prediction
    Elfiky, Abdo A.
    Ibrahim, Ibrahim M.
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2021, 39 (14): : 5248 - 5260
  • [3] GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage
    Ha, Dat P. P.
    Shin, Woo-Jin
    Hernandez, Juan Carlos
    Neamati, Nouri
    Dubeau, Louis
    Machida, Keigo
    Lee, Amy S. S.
    VIRUSES-BASEL, 2023, 15 (05):
  • [4] In silico validation of potent phytochemical orientin as inhibitor of SARS-CoV-2 spike and host cell receptor GRP78 binding
    Bhowmik, Arijit
    Biswas, Souradeep
    Hajra, Subhadip
    Saha, Prosenjit
    HELIYON, 2021, 7 (01)
  • [5] Preliminary Virtual Screening Studies to Identify GRP78 Inhibitors Which May Interfere with SARS-CoV-2 Infection
    Palmeira, Andreia
    Sousa, Emilia
    Koseler, Aylin
    Sabirli, Ramazan
    Goren, Tarik
    Turkcuer, Ibrahim
    Kurt, Ozgur
    Pinto, Madalena M.
    Helena Vasconcelos, M.
    PHARMACEUTICALS, 2020, 13 (06) : 1 - 13
  • [6] Recognition through GRP78 is enhanced in the UK, South African, and Brazilian variants of SARS-CoV-2; An in silico perspective
    Ibrahim, Ibrahim M.
    Elfiky, Abdo A.
    Elgohary, Alaa M.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 562 : 89 - 93
  • [7] Host-cell recognition through GRP78 is enhanced in the new UK variant of SARS-CoV-2, in silico
    Elfiky, Abdo A.
    Ibrahim, Ibrahim M.
    JOURNAL OF INFECTION, 2021, 82 (05) : 225 - 227
  • [8] SARS-CoV-2 and other human coronaviruses: Mapping of protease recognition sites, antigenic variation of spike protein and their grouping through molecular phylogenetics
    Chakraborty, Chiranjib
    Sharma, Ashish Ranjan
    Bhattacharya, Manojit
    Saha, Rudra P.
    Ghosh, Sanmitra
    Biswas, Soham
    Samanta, Saikat
    Sharma, Garima
    Agoramoorthy, Govindasamy
    Lee, Sang-Soo
    INFECTION GENETICS AND EVOLUTION, 2021, 89
  • [9] GRP78, a Novel Host Factor for SARS-CoV-2: The Emerging Roles in COVID-19 Related to Metabolic Risk Factors
    Shin, Jihoon
    Toyoda, Shinichiro
    Fukuhara, Atsunori
    Shimomura, Iichiro
    BIOMEDICINES, 2022, 10 (08)
  • [10] Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein
    Heinzelman, Pete
    Romero, Philip A.
    PLOS ONE, 2021, 16 (05):
1234